Basket | Login | Register

 
 
 
 

Clinical trials by condition

Phase III trials

At risk of developing Alzheimer’s dementia

Currently no clinical trials in this category

Prodromal / Mild Cognitive Impairment due to Alzheimer’s disease

  1. GRADUATE 1 & GRADUATE 2
  2. NorAD

Mild Alzheimer's dementia

  1. GAIN
  2. GRADUATE 1 & GRADUATE 2
  3. LUCIDITY
  4. NorAD

Moderate Alzheimer's dementia

  1. GAIN
  2. NorAD

Severe Alzheimer's dementia

Currently no clinical trials in this category

Agitation in Alzheimer's dementia

  1. BREXPIPRAZOLE
  2. SYMBAD
  3. 17-AVP-786-305

People with dementia-related psychosis

Currently no clinical trials in this category

Subjective memory complaints or family history of Alzheimer's disease

  1. LO-MAPT

 

 
 

Last Updated: Friday 27 September 2019

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options